Unknown

Dataset Information

0

Orally bioavailable potent soluble epoxide hydrolase inhibitors.


ABSTRACT: A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane alpha to the urea were prepared and tested as soluble epoxide hydrolase (sEH) inhibitors. This series of compounds showed low nanomolar to picomolar activities against recombinant human sEH. Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes. Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors. We demonstrated that trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid 13g (t-AUCB, IC50 = 1.3 +/- 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.

SUBMITTER: Hwang SH 

PROVIDER: S-EPMC2596069 | BioStudies | 2007-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC3285443 | BioStudies
2015-01-01 | S-EPMC4551118 | BioStudies
2020-01-01 | S-EPMC7352784 | BioStudies
2012-01-01 | S-EPMC3664520 | BioStudies
2012-01-01 | S-EPMC3528350 | BioStudies
1000-01-01 | S-EPMC4269677 | BioStudies
2021-12-07 | GSE185057 | GEO
2021-01-01 | S-EPMC7915306 | BioStudies
1000-01-01 | S-EPMC2697843 | BioStudies
2014-01-01 | S-EPMC4086390 | BioStudies